Farmasierra
Lidia Morena de Dios is a skilled professional in the pharmaceutical field, currently working as a Quality Assurance Technician at Farmasierra since March 2021. Prior experience includes a role as Quality Assurance Trainee at Aristo Pharma Iberia and work as an Adjunct Pharmacist at a pharmacy. Lidia also completed an internship at Hospital Universitario Fundación Alcorcón focused on cytostatics, clinical trials, and human resources. Lidia holds a Master’s degree in Pharmaceutical Development, Production, Quality Control, and Regulatory Affairs from ESAME Pharmaceutical Business School, alongside various certifications, including an Internal Auditor qualification in ISO 9001:2015. Educational achievements also include a Pharmacy degree and training in emergency care from Universidad Complutense de Madrid.
This person is not in any offices
Farmasierra
Grupo Farmasierra is a pharmaceutical group that specialises in research and development and the manufacture, distribution and commercialisation of medicinal products, food supplements and cosmetics. The Group consists of 205 employees distributed in its four business areas; it has a revenue of 40 million euros and is in full growth. It currently has offices in Spain (Madrid, Barcelona). The Group's activity ranges from the preliminary research needed to develop and optimise the production of a medicinal product, food supplements and cosmetics to the integral management of manufacturing its distribution and promotion. Grupo Farmasierra carries out contract manufacturing and technology development services at the international level for the entire European Union, and for over 20 additional countries. Moreover, it provides third parties with distribution services at the national level and commercialises its products in Spain and Portugal. The on-going incorporation of new knowledge is key to the consolidation of all its areas and its expansion over time. Therefore, Grupo Farmasierra attends major international forums on formulation and pharmaceutical innovation and is in contact with the main sources of specialised information, including several universities and research institutes.